+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

United States Biopsy Devices Market Outlook to 2033 - Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others

  • PDF Icon

    Report

  • 71 Pages
  • June 2025
  • Region: United States
  • GlobalData
  • ID: 6108087
The “United States Biopsy Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Biopsy Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices, Biopsy Forceps and Biopsy Punches

The United States Biopsy Devices Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Biopsy Devices Market.
  • Global corporate-level profiles of key companies operating within the United States Biopsy Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Biopsy Devices is segmented as follows:

  • Biopsy Guns
  • Biopsy Needles
  • Vacuum-Assisted Needle Devices
  • Biopsy Forceps
  • Biopsy Punches

Reasons to Buy

The United States Biopsy Devices Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Biopsy Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Biopsy Devices Market, United States
3.1 Biopsy Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Biopsy Guns Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Biopsy Needles Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.4 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.5 Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Biopsy Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Biopsy Guns Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Biopsy Needles Market, United States, Volume (Units), by Segment, 2018-2033
3.2.4 Biopsy Punches Market, United States, Volume (Units), by Segment, 2018-2033
3.2.5 Vacuum-Assisted Needle Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Biopsy Devices Market, United States, Average Price ($) , 2018-2033
3.4 Biopsy Devices Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Biopsy Devices Market
4.1 Becton Dickinson and Co
4.1.1 Company Overview
4.2 Hologic Inc
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Argon Medical Devices Inc
4.4.1 Company Overview
4.5 Merit Medical Systems Inc
4.5.1 Company Overview
4.6 Olympus Corp
4.6.1 Company Overview
4.7 Devicor Medical Products Inc
4.7.1 Company Overview
4.8 Medtronic Plc
4.8.1 Company Overview
4.9 Wilson-Cook Medical Inc
4.9.1 Company Overview
4.10 Integra LifeSciences Holdings Corp
4.10.1 Company Overview
5 Biopsy Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
6.1.2 Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 18, 2025: Industry Leaders Join Mizzou Cybersecurity Advisory Board
7.1.2 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board
7.2 Financial Announcements
7.2.1 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024
7.2.2 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025
7.2.3 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
7.2.4 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30
7.2.5 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results
7.2.6 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.7 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
7.2.8 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
7.2.9 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
7.2.10 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results
7.2.11 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
7.2.12 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
7.2.13 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
7.2.14 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
7.3 Government and Public Interest
7.3.1 Jan 14, 2025: NFCR-Supported Scientists Advance Liquid Biopsy Technology
7.3.2 Jan 06, 2025: FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials
7.3.3 Sep 30, 2024: Study Advocates for Alternative Biopsy Approach to Detecting Prostate Cancer
7.3.4 Jul 09, 2024: BioCryst : ORLADEYO (Berotralstat) Approved in Peru
7.4 Other Significant Developments
7.4.1 Jan 27, 2025: UC Davis Health places order for BiBBInstruments' EndoDrill GI cancer care device
7.4.2 Aug 15, 2024: Alpenglow Biosciences And Partners Secure A Total Of $24m For Development Of Alpenglow’s 3d Spatial Pathology Platform
7.5 Product News
7.5.1 Nov 13, 2024: Fifteen Radiology Partners Physicians Participating in Multiple RSNA 2024 Sessions
7.5.2 Nov 11, 2024: Syndeo Medical Announces European MDR Approval for Two Product Brands
7.5.3 Sep 19, 2024: Northwestern Medicine Study Advocates for Alternative Biopsy Approach for Detecting Prostate Cancer
7.5.4 Sep 13, 2024: Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Biopsy Guns Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Biopsy Needles Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Biopsy Punches Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 6: Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 7: Biopsy Devices Market, United States, Volume (Units), 2018-2033
Table 8: Biopsy Forceps Market, United States, Volume (Units), 2018-2033
Table 9: Biopsy Guns Market, United States, Volume (Units), 2018-2033
Table 10: Biopsy Needles Market, United States, Volume (Units), 2018-2033
Table 11: Biopsy Punches Market, United States, Volume (Units), 2018-2033
Table 12: Vacuum-Assisted Needle Devices Market, United States, Volume (Units), 2018-2033
Table 13: Biopsy Devices Market, United States, Average Price ($), 2018-2033
Table 14: Biopsy Devices Market, United States, Company Share by Revenue ($m), 2024
Table 15: Biopsy Devices Market Pipeline Products
Table 16: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
Table 17: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036
Table 18: Total Number of Primary Research Participants, General Surgery Devices Market, by Country
List of Figures
Figure 1: Biopsy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Biopsy Guns Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Biopsy Needles Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Biopsy Punches Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 6: Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 7: Biopsy Devices Market, United States, Volume (Units), 2018-2033
Figure 8: Biopsy Forceps Market, United States, Volume (Units), 2018-2033
Figure 9: Biopsy Guns Market, United States, Volume (Units), 2018-2033
Figure 10: Biopsy Needles Market, United States, Volume (Units), 2018-2033
Figure 11: Biopsy Punches Market, United States, Volume (Units), 2018-2033
Figure 12: Vacuum-Assisted Needle Devices Market, United States, Volume (Units), 2018-2033
Figure 13: Biopsy Devices Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Acuderm Inc